Dr. Keith Stewart serves as Scientific Adviser at Tempus. He is a consultant in the Division of Hematology and Oncology, at Mayo Clinic. He currently serves as the Carlson and Nelson Endowed Director of the Mayo Clinic Center for Individualized Medicine and is recognized as the Vasek and Anna Maria Polak Professor of Cancer Research. Dr. Stewart’s current responsibilities at Mayo Clinic relate to the application of genomics to human health across the spectrum of discovery, translation and application to clinical practice.

Dr. Stewart has served in several leadership roles across both research and clinical practice at Mayo Clinic, including as Dean for research in Arizona, and as a member of the Arizona Executive Operations Team and Clinical Practice committee. He has served on multiple boards for both non-profit and commercial organizations, including currently as a Non-Executive Board member for Genomics England and the Scientific Advisory Boards of Helix Inc., Veritas Genetics Inc., and the Multiple Myeloma Research Foundation investment fund.

His own research interest is in the genomics and treatment of myeloma and he has led numerous clinical trials of new drugs for this blood cancer. Dr. Stewart and has authored over 300 journal articles, is named on 28 patents and has served as an associate editor of Blood and ASH Clinical News.